EMA recommends Moderna’s updated Omicron-tailored vaccine
The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months
The European Medical Agency (EMA) yesterday recommended authorisation of Moderna’s COVID-19 vaccine-tailored booster shots for 12 and above ages to further vaccination campaigns in the region.
The agency also authorised Pfizer-BioNTech’s and Moderna’s vaccines for children as young six months.
The updated bivalent booster shots from Moderna will target the original version as well as the BA.4 and the currently dominant BA.5 sub-variants of Omicron.
The European Commission last month approved Moderna’s vaccine targeting the BA.1 subvariant of Omicron.
The recommendation of the agency is based on data from a study that shows Moderna’s bivalent booster shots are more effective than the originally authorised vaccine against the BA.4 and BA.5 sub-variants.
Edits by EP News Bureau